Skip to navigation Skip to content

Clinical Trial: Copaxone plus Estriol



Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756
See Map

A combination trial of Copaxone plus Estriol in relapsing-remitting Multiple Sclerosis

Recruitment Period:
June 2007- ongoing

Location of Study/Trial :
Dartmouth-Hitchcock Medical Center,
One Medical Center Drive,
Lebanon, NH 03756

Females 18-50 with relapsing-remitting MS, who are able to walk without any assistive aids such as a cane or walker, and have had at least one relapse within the last 2 years.
Disqualification criteria
- Women who are pregnant and/or breast-feeding
- Smokers
- Women who have other serious medical conditions

Principal Investigator: 
Vijay M. Thadani
Director, Dartmouth-Hitchcock Medical Center, MS Center.

funded by the National MS Society and the National Institutes of Health.

Description of Study/Trial:
The purpose of this study is to determine if the use of oral Estriol in combination with Copaxone injections is safe; if the use of combination treatment causes a decrease in relapse rates; if there is more rapid improvement on brain MRI with the combination treatment; if there is an improvement in disability measures with the combination treatment.

Subjects will be seen by neurologists, gynecologists and for cognitive testing during the study visits, which will be over 24 months.

Subjects will be required to travel to Dartmouth-Hitchcock medical center for appointments.

Contact information

Laurie Rizzo, Study Coordinator


Chapter HomeReturn to list
© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.